✦ LIBER ✦

Effects of Pioglitazone and Metformin Fixed-Dose Combination Therapy on Cardiovascular Risk Markers of Inflammation and Lipid Profile Compared With Pioglitazone and Metformin Monotherapy in Patients With Type 2 Diabetes

✍ Scribed by Alfonso Perez; Randal Jacks; Vipin Arora; Robert Spanheimer

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Initial therapy with the fixed-dose comb

✍ J. Wainstein; L. Katz; S. S. Engel; L. Xu; G. T. Golm; S. Hussain; E. A. O’Neill 📂 Article 📅 2011 🏛 John Wiley and Sons 🌐 English ⚖ 624 KB

The effect of initial therapy with the f

✍ C. Reasner; L. Olansky; T. L. Seck; D. E. Williams-Herman; M. Chen; L. Terranell 📂 Article 📅 2011 🏛 John Wiley and Sons 🌐 English ⚖ 674 KB

Initial treatment with rosiglitazone/met

✍ J. Rosenstock; J. Rood; A. Cobitz; N. Biswas; H. Chou; A. Garber 📂 Article 📅 2006 🏛 John Wiley and Sons 🌐 English ⚖ 284 KB

Metformin–pioglitazone and metformin–ros

✍ G. Derosa; A. D'Angelo; P. D. Ragonesi; L. Ciccarelli; M. N. Piccinni; F. Pricol 📂 Article 📅 2006 🏛 John Wiley and Sons 🌐 English ⚖ 116 KB

Response to Pokharna and Kanna: Initial

✍ A. Garber 📂 Article 📅 2008 🏛 John Wiley and Sons 🌐 English ⚖ 41 KB

Efficacy and safety of sitagliptin and t

✍ A. Pérez-Monteverde; T. Seck; L. Xu; M. A. Lee; C. M. Sisk; D. E. Williams-Herm 📂 Article 📅 2011 🏛 John Wiley and Sons 🌐 English ⚖ 217 KB